STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
ALKS ALKERMES PUBLIC LIMITED COMPANY StockScouter® Report
5
StockScouter® Score
ALKERMES PUBLIC LIMITED COMPANY, a mid cap growth company in the healthcare sector, is expected to perform in line with the market over the next six months with slightly less than average risk
10 is the best possible rating. Learn more.
Summary
Positives
- Earnings growth in the past year has accelerated moderately compared to earnings growth in the past three years. Positive
- The enterprise value-to-sales ratio is approximately in line with that of comparably-sized companies in the StockScouter universe. Neutral
Concerns
- The most recent quarterly earnings report was significantly lower than analysts’ consensus forecast. Negative
- One or more analysts has modestly decreased quarterly earnings estimates for ALKS. Negative
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that mid cap stocks will be out of favor, growth stocks will be out of favor, and healthcare stocks will be out of favor.
Expected Risk/Return
Core Model Grades
D
D
C
D